Prof. Dr. Dr. med. Antonio Cozzio
Chefarzt/Chefärztin
Dermatologie | Venerologie | Allergologie · Dept. IV
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Wyss N, Berner F, Walter V, Jochum A, Purde M, Abdou M, Sinnberg T, Hofmeister K, Pop O, Hasan A, Bauer J, Cheng H, Lütge M, Klümper N, Diem S, Kosaloglu-Yalcin Z, Zhang Y, Sellmer L, Macek B, Karbach J, König D, Läubli H, Zender L, Meyer B, Driessen C, Schürch C, Jochum W, Amaral T, Heinzerling L, Cozzio A, Hegazy A, Schneider T, Brutsche M, Sette A, Lenz T, Walz J, Rammensee H, Früh M, Jäger E, Becher B, Tufman A, Núñez N, Jörger M, Flatz L. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. Am J Respir Crit Care Med 2024; 210:919-930.
01.10.2024Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
01.10.2024Am J Respir Crit Care Med 2024; 210:919-930
Wyss Nina, Berner Fiamma, Walter Vincent, Jochum Ann-Kristin, Purde Mette T, Abdou Marie-Therese, Sinnberg Tobias, Hofmeister Kathrin, Pop Oltin, Hasan Ali, Bauer Jens, Cheng Hung-Wei, Lütge Mechthild, Klümper Niklas, Diem Stefan, Kosaloglu-Yalcin Zeynep, Zhang Yizheng, Sellmer Laura, Macek Boris, Karbach Julia, König David, Läubli Heinz, Zender Lars, Meyer Britta S, Driessen Christoph, Schürch Christian M, Jochum Wolfram, Amaral Teresa, Heinzerling Lucie M, Cozzio Antonio, Hegazy AhN, Schneider Tino, Brutsche Martin, Sette Alessandro, Lenz Tobias L, Walz Juliane Sarah, Rammensee Hans-Georg, Früh Martin, Jäger Elke, Becher Burkhard, Tufman Amanda, Núñez Nicolás Gonzalo, Jörger Markus, Flatz Lukas
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
Verardi F, Maul L, Borsky K, Steinmann S, Rosset N, Pons H, Sorbe C, Yawalkar N, Micheroli R, Egeberg A, Thyssen J, Heidemeyer K, Boehncke W, Conrad C, Cozzio A, Pinter A, Kündig T, Navarini A, Maul J. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). J Eur Acad Dermatol Venereol 2023
12.12.2023Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
12.12.2023J Eur Acad Dermatol Venereol 2023
Verardi Fabio, Maul Lara Valeska, Borsky Kim, Steinmann Simona, Rosset Nina, Pons Hector Ortega, Sorbe Christina, Yawalkar Nikhil, Micheroli Raphael, Egeberg Alexander, Thyssen Jacob P, Heidemeyer Kristine, Boehncke Wolf-Henning, Conrad Curdin, Cozzio Antonio, Pinter Andreas, Kündig Thomas M, Navarini Alexander A, Maul Julia-Tatjana
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
Wagner N, Lenders M, Kühl K, Reinhardt L, Fuchß M, Ring N, Stäger R, Zellweger C, Ebel C, Kimeswenger S, Oellinger A, Amaral T, Forschner A, Leiter U, Klumpp B, Hoetzenecker W, Terheyden P, Mangana J, Loquai C, Cozzio A, Garbe C, Meier F, Eigentler T, Flatz L. Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy. Eur J Cancer 2023; 196:113425.
21.11.2023Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy.
21.11.2023Eur J Cancer 2023; 196:113425
Wagner Nikolaus, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, Fuchß Milena, Ring Natalie, Stäger Ramon, Zellweger Caroline, Ebel Chiara, Kimeswenger Susanne, Oellinger Angela, Amaral Teresa, Forschner Andrea, Leiter Ulrike, Klumpp Bernhard, Hoetzenecker Wolfram, Terheyden Patrick, Mangana Joanna, Loquai Carmen, Cozzio Antonio, Garbe Claus, Meier Friedegund, Eigentler Thomas Kurt, Flatz Lukas
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Lichtensteiger C, Koblischke M, Berner F, Jochum A, Sinnberg T, Balciunaite B, Purde M, Walter V, Abdou M, Hofmeister K, Kohler P, Vernazza P, Albrich W, Kahlert C, Zoufaly A, Traugott M, Kern L, Pietsch U, Kleger G, Filipovic M, Kneilling M, Cozzio A, Pop O, Bomze D, Bergthaler A, Hasan A, Aberle J, Flatz L. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023; 140:103118.
10.10.2023Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
10.10.2023J Autoimmun 2023; 140:103118
Lichtensteiger Christa, Koblischke Maximilian, Berner Fiamma, Jochum Ann-Kristin, Sinnberg Tobias, Balciunaite Beatrice, Purde Mette-Triin, Walter Vincent, Abdou Marie-Therese, Hofmeister Kathrin, Kohler Philipp, Vernazza Pietro L, Albrich Werner, Kahlert Christian, Zoufaly Alexander, Traugott Marianna T, Kern Lukas, Pietsch Urs, Kleger Gian-Reto, Filipovic Miodrag, Kneilling Manfred, Cozzio Antonio, Pop Oltin, Bomze David, Bergthaler Andreas, Hasan Ali, Aberle Judith, Flatz Lukas
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova-Hötzenecker E, Gniadecki R, Hodak E, Jonak C, Klemke C, Knobler R, Morrris S, Nicolay J, Ortiz-Romero P, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer M, Wehkamp U, Whittaker S, Willemze R, Trautinger F. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023. Eur J Cancer 2023; 195:113343.
18.09.2023EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
18.09.2023Eur J Cancer 2023; 195:113343
Latzka Johanna, Assaf Chalid, Bagot Martine, Cozzio Antonio, Dummer Reinhard, Guenova-Hötzenecker Emmanuella, Gniadecki Robert, Hodak Emmilia, Jonak Constanze, Klemke Claus-Detlev, Knobler Robert, Morrris Stephen, Nicolay Jan P, Ortiz-Romero Pablo L, Papadavid Evangelia, Pimpinelli Nicola, Quaglino Pietro, Ranki Annamari, Scarisbrick Julia, Stadler Rudolf, Väkevä Liisa, Vermeer Maarten H, Wehkamp Ulrike, Whittaker Sean, Willemze Rein, Trautinger Franz
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
Amaral T, Pop O, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring S, Jörger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch C, Forschner A, Flatz L. EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. J Am Acad Dermatol 2023; 89:1072-1074.
22.07.2023EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
22.07.2023J Am Acad Dermatol 2023; 89:1072-1074
Amaral Teresa, Pop Oltin Tiberiu, Chatziioannou Eftychia, Sinnberg Tobias, Niessner Heike, Zhao Jing Hua, Ring Sandra Stephanie, Jörger Markus, Schroeder Christopher, Armeanu-Ebinger Sorin, Cozzio Antonio, Leiter Ulrike, Thomas Ioannis, Jochum Wolfram, Garbe Claus, Forchhammer Stephan, Levesque Mitchell Paul, Mangana Joanna, Hölzel Michael, Dummer Reinhard, Schürch Christian M, Forschner Andrea, Flatz Lukas
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
Quaglino P, Scarisbrick J, Roccuzzo G, Abeldano A, Battistella M, McCormack C, Cowan R, Cozzio A, Cury-Martins J, Enz P, Geskin L, Guenova-Hötzenecker E, Kim Y, Knobler R, Litvinov I, Miyagaki T, Molgo M, Nicolay J, Papadavid E, Pinter-Brown L, Pujol Vallverdu R, Querfeld C, Ortiz-Romero P, Stadler R, Vermeer M, Bagot M, Hodak E. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey. J Eur Acad Dermatol Venereol 2023; 37:680-688.
17.01.2023Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
17.01.2023J Eur Acad Dermatol Venereol 2023; 37:680-688
Quaglino Pietro, Scarisbrick Julia, Roccuzzo Gabriele, Abeldano Alejandra, Battistella Maxime, McCormack Chris, Cowan Richard, Cozzio Antonio, Cury-Martins Jade, Enz Paula, Geskin Larisa, Guenova-Hötzenecker Emmanuella, Kim Youn H, Knobler Robert, Litvinov Ivan V, Miyagaki Tomomitsu, Molgo Montserrat, Nicolay Jan P, Papadavid Evangelina, Pinter-Brown Lauren, Pujol Vallverdu Ramon, Querfeld Christiane, Ortiz-Romero Pablo L, Stadler Rudolf, Vermeer Maarten H, Bagot Martine, Hodak Emmilia
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E, Nägeli M, Hunger R, Merat R, Gaide O, Navarini A, Cozzio A, Wagner N, Maul L, Dummer R. Swiss Recommendations for Cutaneous Basal Cell Carcinoma. Dermatology 2022; 239:1-10.
22.09.2022Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
22.09.2022Dermatology 2022; 239:1-10
Ramelyte Egle, Nägeli Mirjam, Hunger Robert, Merat Rastine, Gaide Olivier, Navarini Alexander A, Cozzio Antonio, Wagner Nikolaus, Maul Lara Valeska, Dummer Reinhard
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
Kostner L, Cerminara S, Pamplona G, Maul J, Dummer R, Ramelyte E, Mangana J, Wagner N, Cozzio A, Kreiter S, Kogler A, Streit M, Wysocki A, Zippelius A, Läubli H, Navarini A, Maul L. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers (Basel) 2022; 14
10.05.2022Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
10.05.2022Cancers (Basel) 2022; 14
Kostner Lisa, Cerminara Sara Elisa, Pamplona Gustavo Santo Pedro, Maul Julia-Tatjana, Dummer Reinhard, Ramelyte Egle, Mangana Johanna, Wagner Nikolaus, Cozzio Antonio, Kreiter Saskia, Kogler Angelika, Streit Markus, Wysocki Anja, Zippelius Alfred, Läubli Heinz, Navarini Alexander, Maul Lara Valeska
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
Dippel E, Assaf C, Becker J, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich H, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke C, Loquai C, Meiß F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021. J Dtsch Dermatol Ges 2022; 20:537-554.
01.04.2022S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.
01.04.2022J Dtsch Dermatol Ges 2022; 20:537-554
Dippel Edgar, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Bernreiter Sophie, Cozzio Antonio, Eich Hans, Elsayad Khaled, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Klemke Claus-Detlev, Loquai Carmen, Meiß Frank, Mitteldorf Christina, Wehkamp Ulrike, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stranzenbach René, Moritz Rose, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Stadler Rudolf
S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021.
Dippel E, Assaf C, Becker J, von Bergwelt-Baildon M, Bernreiter S, Cozzio A, Eich H, Elsayad K, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke C, Loquai C, Meiß F, Mitteldorf C, Wehkamp U, Nashan D, Nicolay J, Oschlies I, Schlaak M, Stranzenbach R, Moritz R, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021. J Dtsch Dermatol Ges 2022; 20:537-555.
01.04.2022S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021.
01.04.2022J Dtsch Dermatol Ges 2022; 20:537-555
Dippel Edgar, Assaf Chalid, Becker Jürgen C, von Bergwelt-Baildon Michael, Bernreiter Sophie, Cozzio Antonio, Eich Hans, Elsayad Khaled, Follmann Markus, Grabbe Stephan, Hillen Uwe, Klapper Wolfram, Klemke Claus-Detlev, Loquai Carmen, Meiß Frank, Mitteldorf Christina, Wehkamp Ulrike, Nashan Dorothee, Nicolay Jan P, Oschlies Ilske, Schlaak Max, Stranzenbach René, Moritz Rose, Stoll Christoph, Vag Tibor, Weichenthal Michael, Wobser Marion, Stadler Rudolf
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Zehnder M, Amarov B, Abrunhosa-Branquinho A, Maiwald-Urosevic M, Mühleisen B, Saulite I, Anzengruber F, Imhof L, Navarini A, Cozzio A, Dummer R, Dimitriou F, Guenova E. Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Dermatology 2022; 238:967-976.
14.02.2022Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
14.02.2022Dermatology 2022; 238:967-976
Zehnder Mara, Amarov Boyko, Abrunhosa-Branquinho André N, Maiwald-Urosevic Mirjana, Mühleisen Beda, Saulite Ieva, Anzengruber Florian, Imhof Laurence, Navarini Alexander A, Cozzio Antonio, Dummer Reinhard, Dimitriou Florentia, Guenova Emmanuella
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Berner F, Niederer R, Luimstra J, Pop O, Jochum A, Purde M, Hasan Ali O, Bomze D, Bauer J, Freudenmann L, Marcu A, Wolfschmitt E, Haen S, Gross T, Dubbelaar M, Abdou M, Baumgaertner P, Appenzeller C, Cicin-Sain C, Lenz T, Speiser D, Ludewig B, Driessen C, Jörger M, Früh M, Jochum W, Cozzio A, Rammensee H, Walz J, Neefjes J, Flatz L. Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival. Oncoimmunology 2021; 10:2006893.
27.11.2021Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
27.11.2021Oncoimmunology 2021; 10:2006893
Berner Fiamma, Niederer Rebekka, Luimstra Jolien J, Pop Oltin Tiberiu, Jochum Ann-Kristin, Purde Mette-Triin, Hasan Ali Omar, Bomze David, Bauer Jens, Freudenmann Lena Katharina, Marcu Ana, Wolfschmitt Eva-Maria, Haen Sebastian, Gross Thorben, Dubbelaar MariLisa, Abdou Marie-Therese, Baumgaertner Petra, Appenzeller Christina, Cicin-Sain Caroline, Lenz Tobias, Speiser Daniel E, Ludewig Burkhard, Driessen Christoph, Jörger Markus, Früh Martin, Jochum Wolfram, Cozzio Antonio, Rammensee Hans-Georg, Walz Juliane, Neefjes Jacques, Flatz Lukas
Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
Haller C, Cozzio A, von Kempis J, Rubbert-Roth A. Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis. J Clin Rheumatol 2021; 27:e289-e290.
01.10.2021Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
01.10.2021J Clin Rheumatol 2021; 27:e289-e290
Haller Christoph, Cozzio Antonio, von Kempis Johannes, Rubbert-Roth Andrea
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity
Papadavid E, Bagot M, Hodak E, Guenova E, Guiron R, Dimitriou F, Cozzio A, Vico C, Ortiz-Romero P, Quaglino P, Engelina S, Porkert S, Jonak C, Dalamaga M, Iliakis T, Nikolaou V, Pappa V, Kapniari E, Scarisbrick J. Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity. Br J Dermatol 2021; 185:1035-1044.
17.08.2021Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity
17.08.2021Br J Dermatol 2021; 185:1035-1044
Papadavid E, Bagot M, Hodak E, Guenova E, Guiron R, Dimitriou F, Cozzio Antonio, Vico C, Ortiz-Romero P L, Quaglino P, Engelina S, Porkert S, Jonak C, Dalamaga M, Iliakis T, Nikolaou V, Pappa V, Kapniari E, Scarisbrick J
Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
Maredia H, Cozzio A, Dummer R, Ramelyte E, Kim E, Rozati S. Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome. JAAD Case Rep 2021; 15:92-96.
21.07.2021Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
21.07.2021JAAD Case Rep 2021; 15:92-96
Maredia Hasina, Cozzio Antonio, Dummer Reinhard, Ramelyte Egle, Kim Ellen J, Rozati Sima
NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism
Roider E, Acuna-Alonso V, Canizales-Quinteros S, Bortolini M, Gonzalez-José R, Ruzicka T, Berking C, Iliopoulos O, Kemény L, Nguyen N, Hsiao J, Navarini A, Gallo C, Poletti G, Fisher D, Ruiz-Linares A, Nijsten T, Zon L, Tishkoff S, Kleinstiver B, Chao L, Schiaffino M, Ito S, Rothhammer F, Bedoya G, Cozzio A, Németh I, Lovas A, Igras V, Wakamatsu K, Suita Y, Kawakami A, Fan S, Kato S, McConnell A, Lee J, Pardo L, Adhikari K, Rachmin I, Zhang J, Navarro P, Osseiran S, Wang H, Weng Q, Evans C, Won C, Lo J, Mujahid N, Itin K, Christie K, Noonan H, Lugo C, Allouche J. NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. Cell 2021; 184:4268-4283.e20.
06.07.2021NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism
06.07.2021Cell 2021; 184:4268-4283.e20
Roider Elisabeth, Acuna-Alonso Victor, Canizales-Quinteros Samuel, Bortolini Maria-Cátira, Gonzalez-José Rolando, Ruzicka Thomas, Berking Carola, Iliopoulos Othon, Kemény Lajos V, Nguyen Nhu, Hsiao Jennifer J, Navarini Alexander A, Gallo Carla, Poletti Giovanni, Fisher David E, Ruiz-Linares Andrés, Nijsten Tamar, Zon Leonard I, Tishkoff Sarah, Kleinstiver Benjamin P, Chao Luke H, Schiaffino Maria Vittoria, Ito Shosuke, Rothhammer Francisco, Bedoya Gabriel, Cozzio Antonio, Németh István, Lovas Alyssa, Igras Vivien, Wakamatsu Kazumasa, Suita Yusuke, Kawakami Akinori, Fan Shaohua, Kato Shinichiro, McConnell Alicia M, Lee Ju Hee, Pardo Luba M, Adhikari Kaustubh, Rachmin Inbal, Zhang Jianming, Navarro Paula P, Osseiran Sam, Wang Hequn, Weng Qing Yu, Evans Conor L, Won Chong Hyun, Lo Jennifer A, Mujahid Nisma, Itin Kaspar, Christie Kathleen A, Noonan Haley R, Lugo Camila Makhlouta, Allouche Jennifer
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Maul J, Dippel M, Yawalkar N, Trüeb R, Schlapbach C, Mainetti C, Lapointe A, Laffitte E, Kolios A, Jalili A, Häusermann P, Cozzio A, Conrad C, Anzengruber F, Navarini A. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology 2021; 237:166-178.
06.01.2021Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
06.01.2021Dermatology 2021; 237:166-178
Maul Julia-Tatjana, Dippel Michaela, Yawalkar Nikhil, Trüeb Ralph, Schlapbach Christoph, Mainetti Carlo, Lapointe Anne-Karine, Laffitte Emmanuel, Kolios Antonios G A, Jalili Ahmad, Häusermann Peter, Cozzio Antonio, Conrad Curdin, Anzengruber Florian, Navarini Alexander A
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Wagner N, Schraag A, Klumpp B, Hoetzenecker W, Berking C, Richtig E, Ziemer M, Mangana J, Terheyden P, Loquai C, Nguyen V, Gebhardt C, Meier F, Diem S, Cozzio A, Flatz L, Röcken M, Garbe C, Gassenmaier M, Weide B, Leiter U, Lenders M, Kühl K, Reinhardt L, André F, Dudda M, Ring N, Ebel C, Stäger R, Zellweger C, Lang R, Paar M, Gussek P, Richtig G, Stürmer S, Kimeswenger S, Oellinger A, Forschner A, Eigentler T. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. J Immunother Cancer 2021; 9
01.01.2021Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
01.01.2021J Immunother Cancer 2021; 9
Wagner Nikolaus, Schraag Amadeus, Klumpp Bernhard, Hoetzenecker Wolfram, Berking Carola, Richtig Erika, Ziemer Mirjana, Mangana Johanna, Terheyden Patrick, Loquai Carmen, Nguyen Van Anh, Gebhardt Christoffer, Meier Friedegund, Diem Stefan, Cozzio Antonio, Flatz Lukas, Röcken Martin, Garbe Claus, Gassenmaier Maximilian, Weide Benjamin, Leiter Ulrike, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, André Fiona, Dudda Milena, Ring Natalie, Ebel Chiara, Stäger Ramon, Zellweger Caroline, Lang Roland, Paar Michael, Gussek Philipp, Richtig Georg, Stürmer Suzan H, Kimeswenger Susanne, Oellinger Angela, Forschner Andrea, Eigentler Thomas K
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
Stenz N, Hofbauer G, Nägeli M, Mühlstädt M, Laffitte E, Hunger R, Harms M, Gaide O, Dickenmann M, Cozzio A, Arnold A, Stampf S, and The Swiss Transplant Cohort Study. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). Dermatology 2020:1-11.
23.11.2020Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
23.11.2020Dermatology 2020:1-11
Stenz Nadja Angela, Hofbauer Günther F L, Nägeli Mirjam, Mühlstädt Michael, Laffitte Emmanuel, Hunger Robert E, Harms Mirjam, Gaide Olivier, Dickenmann Michael, Cozzio Antonio, Arnold Andreas W, Stampf Susanne, and The Swiss Transplant Cohort Study